You’re Invited…. Treatment options for metastatic colorectal carcinoma (mCRC) have evolved significantly in the past 10 to 15 years from one drug to 7 drugs, and include traditional antineoplastic agents as well as targeted antibody therapies. While many gains in oncology have been made through novel drug combinations, recent data suggest that more is not always better. The choice of treatment regimen for patients with mCRC is further complicated by growing evidence suggesting a differential response based on mutation status of key biomarkers such as KRAS. Please join Dr. Marshall as he sheds light on these recent developments and provides insight into the challenges associated with selecting an optimal therapeutic approach.
Advancing the Treatment of Metastatic Colorectal Cancer: A Road Paved With Good Intentions
John L. Marshall, MD Chief, Division of Hematology & Oncology Lombardi Comprehensive Cancer Center Georgetown University Washington, DC
During this seminar, Dr. Marshall will provide an overview of the treatment advances in mCRC, review data from recent clinical trials and discuss the factors that physicians consider when determining the best therapeutic approach for patients with mCRC.
Monday, June 22, 2009 Time: Pacific 9:00–10:30 am Mountain 10:00–11:30 am Central Standard 10:00–11:30 am Central Daylight 11:00–12:30 pm Eastern 12:00–1:30 pm Atlantic 1:00–2:30 pm Newfoundland 1:30–3:00 pm Register at: www.oncologywebcastseries.ca
Made possible by an educational grant from Amgen Canada.
Série de webémissions oncologie
Vous êtes invité… Les options de traitement pour le cancer colorectal métastatique, qui comprennent les agents antinéoplasiques classiques ainsi que les thérapies ciblées par anticorps, ont énormément évolué au cours de ces 10 à 15 dernières années, passant d’un médicament à sept médicaments. Bien que de nombreux progrès aient été accomplis en oncologie grâce à l’utilisation de nouvelles associations médicamenteuses, des données récentes laissent entendre que la combinasion de nouveaux traitements n’est pas toujours associée à une amélioration des soins. Le choix d’un schéma thérapeutique chez les patients atteints d’un cancer colorectal métastatique devient de plus en plus complexe si l’on se fie aux récentes données qui montrent une réponse différentielle fondée sur le statut de mutation de biomarqueurs clés tels que KRAS. Veuillez assister au séminaire du Dr Marshall au cours duquel y seront présentés ces tous derniers développements ainsi qu’un aperçu des défis associés à la sélection d’une approche thérapeutique optimale.
Avancées dans le traitement du cancer colorectal métastatique : une route pavée de bonnes intentions
John L. Marshall, MD Chef, Division d’hématologie/oncologie Lombardi Comprehensive Cancer Center Georgetown University Washington, DC
Durant ce séminaire, le Dr Marshall donnera un aperçu des progrès réalisés dans le traitement du cancer colorectal métastatique, passera en revue les données des plus récents essais cliniques et présentera les facteurs dont tiennent compte les médecins au moment de déterminer la meilleure approche thérapeutique pour les patients atteints
d’un cancer colorectal métastatique.
Lundi 22 juin 2009 Heure :
Pacifique des Rocheuses Heure du centre Heure avancée du centre de l’Est de l’Atlantique Terre-Neuve
May 14, 2013 - If you would like a copy of the presentation slides, click the PDF link in ...... Cisco BGP Dynamic Route Leaking feature Interaction with Juniper.
Dec 19, 2013 - analysis, according to national and POLA policies. ... 32-bit software). ..... myosin 1B; TFPI, tissue factor pathway inhibitor; SPRY1, sprouty homolog 1, .... Therapeutic application of noncytotoxic molecular targeted therapy.
variation in sample collection, processing and storage, have been reported as problematic with this ... methods and specific and sensitive biomarkers, both scientist and .... applied to SELDI-MS ProteinChip arrays and protein expression .... Lung. 2.
Western College of Veterinary Medicine ..... Hemopoietic tumors are the most commonly diagnosed neoplasms of the cat accounting for around 30â ...... The answers to these questions will be helpful in formulating a definitive plan for treatment. 1.
Fire Edition, Histoire Des Trait S De 1815 Et De Leur Ex Cution Publi E Sur Les Documents Officiels. Et In Dits, Historical Dictionary Of The Cooperative ...
Jan 23, 2009 - the maximum free concentration of daptomycin measured 0.5 h after admin- istration of the dose and is equal to 24 h. Statistical analysis.
1 juin 2017 - Executive Director ... recording, or any information storage and retrieval system, without express ..... immune system against the cancer.
Nov 16, 2006 - Benguela Rail Line Lobito, Angola, the Chinese rebuild available approx. end of fourth quarter 2007. East/West transport will reduce timelines-- ...
Take time to read through this manual before embarking on your journey through the ..... add at least one additional calibration star to improve the mount's all-sky ...
Installation Instructions. Shut Off Water Supplies. 1. Position faucet and/or gasket on lavatory. Use silicone sealant between faucet and lavatory to prevent water ...
smooth transition from red to orange and notes that âborderline cases are cases for which looking red ... is shifted depending on the order of presentation. In her.
WARNING Read all safety warnings and in- structions. ... This will ensure that the safety of the heated ..... site internet www.milwaukeetool.com ou contactez.
medical devices, consult the devise manufacturer and/or your physician to .... Return of the Heated Jacket to a MILWAUKEE factory Service Center location, freight prepaid and ..... Miguel Hidalgo, Distrito Federal, México. 01 (800) 030-7777 o ...
High and the red LED will light. Temperature setting can be ..... 11/17. Printed in China. MILWAUKEE TOOL. 13135 West Lisbon Road. Brookfield, WI 53005 USA.
medical devices, consult the devise manufacturer and/or your physician .... Heated Jacket to a MILWAUKEE factory Service Center location, freight prepaid and ...
dangerous and must be repaired. • Disconnect the battery pack from the heated hoodie before storing. Such preventive safety mea- sures reduce the risk of ...
repair person using only identical replacement parts. ... a helpless person, or anyone insensitive to heat, ... If the heated jacket turns off unexpectedly, check.